MabGenesis Inc. filed for an IPO
MabGenesis Inc., a Japan-based biotech startup, has officially filed for an IPO on the JPX, focusing on monoclonal antibody drugs for humans and pets.
JPX · Biotech

#IPO #JPX #Biotech #Japan #IPONews #monoclonalantibodies #biopharmaceuticals

#LassaFever remains a global health challenge.

This review highlights emerging #antivirals, #MonoclonalAntibodies, and combination therapies that could outperform ribavirin and improve stage-specific treatment.

#OpenAccess in #DIT_Journal: doi.org/10.1016/j.dc...